| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |